Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002

JAMA

Volumn 294, Issue 21, 2005, Pages 2712-2719

  Fry, Alicia M ^a,c   Shay, David K ^b   Holman, Robert C ^a   Curns, Aaron T ^a   Anderson, Larry J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH SURVEY; HEART DISEASE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 28844472594     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.21.2712     Document Type: Article

References (52)

1. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-1340.
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238-1245.
3. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186.
4. Jackson ML, Neuzil KM, Thompson WW, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39:1642-1650.
5. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis. 1999;179:25-30.
6. Simonsen L, Conn LA, Pinner RW, Teutsch S. Trends in infectious disease hospitalizations in the United States, 1980-1994. Arch Intern Med. 1998;158:1923-1928.
7. Falsey AR. Respiratory syncytial virus infection in older persons. Vaccine. 1998;16:1775-1778.
8. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13:371-384.
9. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis. 1994;18:501-513.
10. Marston BJ, Plouffe JF, File TM Jr, et al; Community-Based Pneumonia Incidence Study Group. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. Arch Intern Med. 1997;157:1709-1718.
11. Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med. 1998;105:319-330.
12. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med. 1994;96:313-320.
13. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189:233-238.
14. Farr BM, Wasdworth F, Miller DL; British Thoracic Society Pneumonia Study Group. Risk factors for community-acquired pneumonia diagnosed upon hospital admission. Respir Med. 2000;94:954-963.
15. National Center for Health Statistics. National Hospital Discharge Survey: Multi-Year Data Tape Information, 1988-2002. Hyattsville, Md: National Center for Health Statistics; 2004.
16. Gillium BS, Graves EJ, Kozak LJ. Trends in Hospital Utilization: United States, 1988-92. Hyattsville, Md: National Center for Health Statistics; 1996.
17. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
18. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med. 1993;153:2105-2111.
19. Intercensal Estimates of the Population by Age, Sex, and Race: 1988-2002. Washington, DC: US Census Bureau; 2003.
20. Shah BV, Barnell BG, Bieler GS. SUDAAN User's Manual, Release 7.0. Research Triangle Park, NC: Research Triangle Institute; 1996.
21. Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2005;(158):1729.
22. Dennison C, Pokras R. Design and operation of the National Hospital Discharge Survey: 1988 redesign. Vital Health Stat 1. 2000;(39):1.
23. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med. 2004;164:2113-2118.
24. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US: 1990-1998. Diabetes Care. 2000;23:1278-1283.
25. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
26. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16.
27. Barker WH, Mullooly JP. Stroke in a defined elderly population, 1967-1985: a less lethal and disabling but no less common disease. Stroke. 1997;28:284-290.
28. Shahar E, McGovern PG, Pankow JS, et al. Stroke rates during the 1980s: the Minnesota Stroke Survey. Stroke. 1997;28:275-279.
29. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998;158:1769-1776.
30. Kaplan V, Clermont G, Griffin MF, et al. Pneumonia: still the old man's friend? Arch Intern Med. 2003;163:317-323.
31. Kaplan V, Angus DC, Griffin MF, Clermont G, Watson SR, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165:766-772.
32. Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis. 2003;37:1617-1624.
33. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: final data for 1999. Natl Vital Stat Rep. 2001;49:1-113.
34. Day J. Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050. Washington, DC: US Bureau of Census, US Government Printing Office; 1996.
35. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-250.
36. National Health Interview Survey: influenza vaccination data. Available at: http://www.cdc.gov/flu/professionals/vaccination/pdf/vaccinetrend.pdf. Accessibility verified October 19, 2005.
37. Thompson WW, Shay DK, Weintraub E, et al. Influencing vaccination among the elderly in the Untied States. Arch Intern Med. 2005;165:2038-2039.
38. US Public Health Service. Healthy People: The Surgeon General's Report on Health Promotion and Disease Prevention. Washington, DC: US Dept of Health, Education, and Welfare; 1979. Publication PHS 79-55071.
39. Nuorti JP, Butler JC, Farley MM, et al; Active Bacterial Core Surveillance Team. Cigarette smoking and invasive pneumococcal disease. N Engl J Med. 2000;342:681-689.
40. National Air Quality and Emissions Trends Report: 1989. Research Triangle Park, NC: US Environmental Protection Agency, Office of Air Quality Planning and Standards, Technical Support Division; 1991.
41. Cigarette-smoking attributable morbidity: United States, 2000. MMWR Morb Mortal Wkly Rep. 2003;52:842-844.
42. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2005;54:1-40.
43. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 1997;46:1-24.
44. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325:1453-1460.
45. Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348:1747-1755.
46. Goronzy JJ, Fulbright JW, Crowson CS, et al. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol. 2001;75:12182-12187.
47. de Jong JC, Beyer WE, Palache AM, et al. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol. 2000;61:94-99.
48. Remarque EJ, de Jong JM, van der Klis RJ, et al. Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients. Exp Gerontol. 1999;34:109-115.
49. Dorrell L, Hassan I, Marshall S, Chakraverty P, Ong E. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers. Int J STD AIDS. 1997;8:776-779.
50. McElhaney JE, Beattie BL, Devine R, Grynoch R, Toth EL, Bleackley RC. Age-related decline in interleukin 2 production in response to influenza vaccine. J Am Geriatr Soc. 1990;38:652-658.
51. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. Efficacy of influenza vaccination in elderly individuals: a randomized doubleblind placebo-controlled trial. JAMA. 1994;272:1661-1665.
52. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infections in elderly and high-risk adults. N Engl J Med. 2005;352:1749-1759.